Authors: KAWAI C YUI Y HOSODA S NOBUYOSHI M SUZUKI S SATO H TAKATSU F MOTOMIYA T KANMATSUSE K KODAMA K YABE Y MINAMINO T KIMATA SI NAKASHIMA M SUGIYAMA M SONE T HIASA Y KIJIMA M NAKAMURA N HAYASAKI K ABE H KADOWAKI K MURAYAMA H JOH T KATAGIRI T WATANABE S DOHI K TATEDA K MURATA M HAYASHIDA N ARITA M SAKAI K KITA T TODA H MEGURO T HARADA M HIGUMA N NAGAI T TAKIZAWA A HIRAYAMA H MURAKAMI E HIROSE K ISHISE S SHIMOMURA K INADA M CHINO M HIRAMORI K YOKOYAMA K MUNAKATA T TAKASE S SAITO S DOHI Y NAKAMURA H NISHIMURA H TAKAHASHI T KANAYA H TAKAHASHI M YOKOYAMA M IWASAKI T MITSUTO K HAYASHI Y OKUHARA T MATSUZAKI M YOROZU T TOSHIMA H ISHIKAWA K OGAWA H SYOUGASE T MIYAZAWA Y TAKEDA H SIBATA A YAMAGUCHI H TAKAHASHI S SAITO M NOMURA M TSUNEKAWA J NISHIKAWA H WAKABAYASHI A YOSHIKAWA J SHOJI K SAWAYAMA T HYAKUNA E TAKEDA H KIKUCHI Y DOI T YANO S TANAKA H KIMATA S

Citation: C. Kawai et al., A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND MULTICENTER TRIAL OF A SINGLEBOLUS INJECTION OF THE NOVEL MODIFIED T-PA E6010 IN THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - COMPARISON WITH NATIVE T-PA, Journal of the American College of Cardiology, 29(7), 1997, pp. 1447-1453